Latest News
Featured News
Scancell Preliminary Results for the Year Ended 30 April 2024
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Society of Clinical Oncology Meeting
Issue of share options to Non-Executive Directors
Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting
Block Listing Application to AIM
Scancell Statement re: Silicon Valley Bank (SVB)
Encouraging early efficacy data from monotherapy part of ModiFY Phase 1/2 clinical trial
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.
